Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial

BACKGROUND: We have previously shown lymphocyte density, measured using computational pathology, is associated with pathological complete response (pCR) in breast cancer. The clinical validity of this finding in independent studies, among patients receiving different chemotherapy, is unknown. PATIEN...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, H. R., Dariush, A., Thomas, J., Provenzano, E., Dunn, J., Hiller, L., Vallier, A.-L., Abraham, J., Piper, T., Bartlett, J. M. S., Cameron, D. A., Hayward, L., Brenton, J. D., Pharoah, P. D. P., Irwin, M. J., Walton, N. A., Earl, H. M., Caldas, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834010/
https://www.ncbi.nlm.nih.gov/pubmed/28525534
http://dx.doi.org/10.1093/annonc/mdx266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834010/
https://www.ncbi.nlm.nih.gov/pubmed/28525534
http://dx.doi.org/10.1093/annonc/mdx266

Ejemplares similares